Jeffrey Rubin, MD
NPI 1720125131 · Interventional Pain Medicine Physician · Woodstock, GA
Enrolled with Medicare as Practitioner - Interventional Pain Management · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1720125131
- Entity type
- Individual
- Primary specialty
- Interventional Pain Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- 030873 (GA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,243 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 816 | $89 |
| Testing for Presence of Drug, By Chemistry Analyzers80307 | 405 | $58 |
| Drug Test(s), Definitive, Utilizing (1) Drug Identification Methods Able to Identify Individual Drugs and Distinguish Between Structural Isomers (but Not Necessarily Stereoisomers), Including, But Not Limited to Gc/Ms (any Type, Single Or Tandem) and Lc/MsG0481 | 230 | $150 |
| Drug Test(s), Definitive, Utilizing (1) Drug Identification Methods Able to Identify Individual Drugs and Distinguish Between Structural Isomers (but Not Necessarily Stereoisomers), Including, But Not Limited to Gc/Ms (any Type, Single Or Tandem) and Lc/MsG0480 | 146 | $106 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 137 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 31 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 748 | 141 |
| Oxycodone Hcl/Acetaminophenbrand: Oxycodone-Acetaminophen | 542 | 94 |
| Gabapentin | 532 | 119 |
| Pregabalin | 458 | 79 |
| Duloxetine Hcl | 424 | 87 |
| Tizanidine Hcl | 328 | 64 |
| Oxycodone Hcl |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$46 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-02-01
- Last updated
- 2025-07-08
- Certified
- 2025-07-08
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.